Janux Therapeutics, Inc.JANXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank83
3Y CAGR+0.6%
5Y CAGR+46.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+0.6%/yr
Annual compound
5Y CAGR
+46.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
6.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $52.33M | -87.8% |
| 2024 | $430.61M | +2142.2% |
| 2023 | $19.20M | -62.7% |
| 2022 | $51.43M | +44.5% |
| 2021 | $35.58M | +355.4% |
| 2020 | $7.81M | +1087.4% |
| 2019 | $658000.00 | - |